Columbia Research Enhanced Value ETF Rating $27.69 -0.01 (-0.04%) Closing price 04:10 PM EasternExtended Trading$27.70 +0.00 (+0.02%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Columbia Research Enhanced Value ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.REVS Aggregate RatingModerate Buy 2.59Holdings in REVS have an aggregate rating of Moderate Buy based on 588 analyst ratings issued in the past year covering 23 companies (41.2% of the portfolio).REVS Aggregate Price Target$27.69High Prediction$27.69Average Prediction$27.69Low Prediction$27.69Holdings in REVS have an aggregate price target of $27.69 and a range of $27.69 to $27.69 covering 23 companies (41.2% of the portfolio).REVS Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Columbia Research Enhanced Value ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 REVS Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.39%JPMJPMorgan Chase & Co.$300.81+0.5%4.7398 of 5 stars2.52$288.68 -4.0%23Trending News2.48%PFEPfizer$24.60-1.9%4.8806 of 5 stars2.39$28.12 14.3%18Trending News2.46%CSCOCisco Systems$69.43+1.4%4.8214 of 5 stars2.63$74.53 7.3%24Positive NewsInsider Trade2.27%XOMExxon Mobil$113.43+0.6%4.9318 of 5 stars2.43$125.00 10.2%21Trending NewsInsider Trade2.21%MOAltria Group$66.400.0%4.166 of 5 stars2.00$60.88 -8.3%9Positive NewsDividend Increase1.91%LOWLowe's Companies$257.65-0.4%4.7507 of 5 stars2.58$283.92 10.2%26Dividend IncreaseInsider TradeAnalyst Revision1.91%CRMSalesforce$254.79+1.9%4.9741 of 5 stars2.80$340.54 33.7%41Trending NewsUpcoming EarningsAnalyst ForecastInsider Trade1.80%GOOGLAlphabet$211.64+2.0%3.9219 of 5 stars2.86$211.53 -0.1%43Trending News1.78%BLKBlackRock$1,130.50-0.1%4.7337 of 5 stars2.80$1,151.21 1.8%15Trending News1.69%CATCaterpillar$435.14+0.6%4.7101 of 5 stars2.83$450.87 3.6%18Trending News1.67%MSMorgan Stanley$150.16+0.5%4.4405 of 5 stars2.47$138.25 -7.9%15Trending News1.53%CVSCVS Health$72.13+0.3%4.9325 of 5 stars3.05$77.56 7.5%22Positive NewsAnalyst Forecast1.47%GOOGAlphabet$212.37+2.0%4.5913 of 5 stars2.77$215.19 1.3%31Trending News1.45%CCitigroup$96.79-0.1%4.9162 of 5 stars2.67$96.54 -0.3%15Trending News1.44%CVXChevron$159.29+0.0%4.7819 of 5 stars2.36$163.95 2.9%22Positive NewsInsider Trade1.41%BMYBristol Myers Squibb$46.89-1.6%4.7381 of 5 stars2.24$56.38 20.2%21Positive News1.30%QCOMQUALCOMM$160.80+0.6%4.9577 of 5 stars2.54$182.82 13.7%24Trending NewsAnalyst Upgrade1.26%CICigna Group$298.98-0.3%5 of 5 stars3.00$374.82 25.4%19Positive NewsAnalyst Forecast1.24%NKENIKE$77.98-0.1%4.5016 of 5 stars2.70$78.22 0.3%33Trending NewsAnalyst Upgrade1.24%METAMeta Platforms$751.11+0.5%3.9752 of 5 stars2.96$822.41 9.5%47Trending NewsInsider TradeAnalyst Revision1.23%UNPUnion Pacific$222.42+0.7%4.8272 of 5 stars2.56$258.21 16.1%27Positive News1.08%AMDAdvanced Micro Devices$168.58+0.9%4.2855 of 5 stars2.76$181.33 7.6%38Trending NewsAnalyst UpgradeInsider Trade0.98%TGTTarget$96.86-1.1%4.9533 of 5 stars2.19$113.74 17.4%36Analyst Revision This page (NYSEARCA:REVS) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Columbia Research Enhanced Value ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Columbia Research Enhanced Value ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access